KRISTEN LORCH: Open Payments
NPI 1407529167 · PLAINVIEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 52 payments from 15 companies in 2025. Trend: 2023 $1,159 · 2024 $1,569 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $282 |
| E.R. Squibb & Sons, L.L.C. | 8 | $160 |
| Amgen Inc. | 5 | $117 |
| Novo Nordisk Inc | 4 | $101 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $65 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Inspire Medical Systems, Inc. | 2 | $36 |
Products named: LEQVIO, REPATHA, ELIQUIS, CAMZYOS, VERQUVO, JARDIANCE, NEXLETOL, ENTRESTO.
Industry payments across NY — which companies pay providers there.
